Skip to main content
Full access
Communications and Updates
Published Online: 1 July 2015

Gluten-Free Diet Regimens and Psychiatric Symptoms

To the Editor: The article by William W. Eaton, Ph.D., and colleagues (1), published in the March 2015 issue of the Journal, described the case of an adolescent with complex autoimmune illness, whose psychotic symptoms were found to significantly improve after a gluten-free diet and pharmacological treatment with antidepressant and antipsychotic medication. The authors discussed possible mechanisms implied in patient’s response to the gluten-free diet, arguing for immunological abnormalities and neuroinflammatory processes that may have played a role in the pathogenesis of schizophrenia and autoimmune conditions.
The patient had two previous diagnoses of major depressive disorder with psychotic features, and the family had a history of affective disorder, with both parents having a history of seasonal affective disorder and two grandparents having experienced bouts of depression. In addition, the patient was treated with low dosages of antipsychotics (previously 5 mg/day of aripiprazole, afterward 1.5 mg/day of risperidone) along with antidepressants (previously 10 mg/day of escitalopram, afterward 150 mg/day of venlafaxine). Taken as a whole, these elements suggest the possibility of an affective diathesis rather than schizophrenia. This diagnostic interpretation would not disconfirm the presence of interplaying immuno-inflammatory patterns underlying the genesis of complex autoimmune and psychiatric conditions, like major depressive disorder, as these have been consistently reported (2) along with a positive response following a gluten-free diet in depressed patients (3).
The patient’s gluten sensitization does not conform to a recognized gluten-related disorder subtype. However, celiac disease is suggested by the presence of anti-gliadin antibodies and the relevant autoimmune family history (unfortunately, human leukocyte antigen typing and duodenal histology are unknown), while positivity to specific immunoglobulin E underlines a possible Th2 allergic pathway. Neurological and mood alterations of various severity have been widely reported in all gluten-related disorders, as possible extraintestinal symptoms improving during a gluten-free dietetic regimen. Ultimately, on the basis of the current knowledge and the absence of gluten-free diet side effects, dietotherapy should be further investigated in addition to current pharmacological treatments (4, 5).

References

1.
Eaton WW, Chen LY, Dohan FC Jr, et al: Improvement in psychotic symptoms after a gluten-free diet in a boy with complex autoimmune illness. Am J Psychiatry 2015; 172:219–221
2.
Anderson G, Maes M: Oxidative/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications. Curr Pharm Des 2014; 20:3812–3847
3.
Carr AC: Depressed mood associated with gluten sensitivity: resolution of symptoms with a gluten-free diet. N Z Med J 2012; 125:81–82
4.
Peters SL, Biesiekierski JR, Yelland GW, et al: Randomised clinical trial: gluten may cause depression in subjects with non-coeliac gluten sensitivity: an exploratory clinical study. Aliment Pharmacol Ther 2014; 39:1104–1112
5.
Catassi C, Bai JC, Bonaz B, et al: Non-celiac gluten sensitivity: the new frontier of gluten related disorders. Nutrients 2013; 5:3839–3853

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 685 - 686
PubMed: 26130204

History

Accepted: April 2015
Published online: 1 July 2015
Published in print: July 01, 2015

Authors

Details

Bernardo Dell’Osso, M.D.
From the Department of Mental Health, Department of Pathophysiology and Transplant, University of Milan, Milan, Italy; the Center for the Prevention and Diagnosis of Celiac Disease, Gastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy; and the Bipolar Disorders Clinic, Stanford University, Stanford, Calif.
Luca Elli, M.D.
From the Department of Mental Health, Department of Pathophysiology and Transplant, University of Milan, Milan, Italy; the Center for the Prevention and Diagnosis of Celiac Disease, Gastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy; and the Bipolar Disorders Clinic, Stanford University, Stanford, Calif.

Competing Interests

Dr. Elli is a member of the Dr. Schär Institute Board. Dr. Dell’Osso reports no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share